Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia

References

• Sarma AV, Wei JT. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med. 2012;367:248–257.
   PubMed Web of Science ®Google Scholar
• Wong SY, Woo J, Hong A, et al. Risk factors for lower urinary tract symptoms in southern Chinese men. Urology. 2006;68:1009–1014.
   PubMed Web of Science ®Google Scholar
• Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–1315.
   PubMed Web of Science ®Google Scholar
• Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology. 2002;59:245–250.
   PubMed Web of Science ®Google Scholar
• Trueman P, Hood SC, Nayak US, et al. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int. 1999;83:410–415.
   PubMed Web of Science ®Google Scholar
• Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate. 1993;23:1–7.
   PubMed Web of Science ®Google Scholar
• Ozturk MI, Koca O, Keleş MO, et al. International prostate symptom score: really appreciated by all patients or not? Urol J. 2011;8:227–230.
   PubMed Web of Science ®Google Scholar
• Barry MJ, Fowler FJ, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–1557.
   PubMed Web of Science ®Google Scholar
• van Venrooij GE, Boon TA, de Gier RP. International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol. 1995;153:1516–1519.
   PubMed Web of Science ®Google Scholar
• Asiedu B, Anang Y, Nyarko A, et al. The role of sex steroid hormones in benign prostatic hyperplasia. Aging Male. 2017;20:17–22.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Kim MK, Zhao C, Kim SD, et al. Relationship of sex hormones and nocturia in lower urinary tract symptoms induced by benign prostatic hyperplasia. Aging Male. 2012;15:90–95.
   PubMed Web of Science ®Google Scholar
• Park SG, Yeo JK, Cho DY, et al. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia. Aging Male. 2017;1–5.
   PubMedGoogle Scholar
• Aktas BK, Gokkaya CS, Bulut S, et al. Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male. 2011;14:48–52.
   PubMed Web of Science ®Google Scholar
• Choi EP, Lam CL, Chin W-Y. Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes. 2014;12:1.
   PubMed Web of Science ®Google Scholar
• Choi EP, Chin WY, Lam CLK, et al. The responsiveness of the International Prostate Symptom Score, Incontinence Impact Questionnaire‐7 and Depression, Anxiety and Stress Scale‐21 in patients with lower urinary tract symptoms. J Adv Nurs. 2015;71:1857–1870.
   PubMed Web of Science ®Google Scholar
• Chin WY, Choi EP, Lam CL. The effect of timing of incentive payments on response rates for cohort study telephone interviews in primary care setting with cost-minimization analysis, a randomized controlled trial. BMC Med Res Methodol. 2015;15:79.
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. Health Institute, New England Medical Center; 1995.
   Google Scholar
• Ware JE. How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Boston (MA): QualityMetric Incorporated; 2002.
   Google Scholar
• Lam ET, Lam CLK, Fong DYT, et al. Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese? J Eval Clin Pract. 2013;19:200–208.
   PubMed Web of Science ®Google Scholar
• Lam CL, Wong CK, Lam ET, et al. Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Pract. 2010;32:77–86.
   Google Scholar
• Gloster AT, Rhoades HM, Novy D, et al. Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients. J Affect Disord. 2008;110:248–259.
   PubMed Web of Science ®Google Scholar
• Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44:227–239.
   PubMed Web of Science ®Google Scholar
• Lam TP, Wong JG, Ip MS, et al. Psychological well-being of interns in Hong Kong: what causes them stress and what helps them. Med Teach. 2010;32:e120–e126.
   PubMed Web of Science ®Google Scholar
• Ownsworth T, Little T, Turner B, et al. Assessing emotional status following acquired brain injury: the clinical potential of the depression, anxiety and stress scales. Brain Inj. 2008;22:858–869.
   PubMed Web of Science ®Google Scholar
• Badia X, Garcı´a-Losa M, Dal-Ré R, et al. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology. 1998;52:614–620.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:945–952.
   PubMed Web of Science ®Google Scholar
• Nunnally JC. Psychometric theory. New Delhi: McGraw-Hill; 1978.
   Google Scholar
• Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40:171–178.
   PubMedGoogle Scholar
• Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care. 1990;28:632–642.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217–S232.
   PubMed Web of Science ®Google Scholar
• Quek KF, Low WY, Razack AH, et al. Reliability and validity of the Malay version of the International Prostate Symptom Score in the Malaysian population. J Urol. 2002;167:1359–1362.
   PubMed Web of Science ®Google Scholar